{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T03:25:41Z","timestamp":1787109941787,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejps.2026.107602","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:06:57Z","timestamp":1783440417000},"page":"107602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Antisolvent crystallization of indomethacin cocrystals: Influence of coformers and solvent systems"],"prefix":"10.1016","volume":"225","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4846-353X","authenticated-orcid":false,"given":"Hugo","family":"Pardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"Guarnizo-Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borja","family":"Mart\u00ednez-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Torrado-Salmer\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0908-8286","authenticated-orcid":false,"given":"M. \u00c1ngeles","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ejps.2026.107602_bib0001","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1021\/cg200517r","article-title":"Solubility behaviour and solution chemistry of indomethacin cocrystals in organic solvents","volume":"11","author":"Alhalaweh","year":"2011","journal-title":"Cryst. Growth Des."},{"issue":"5","key":"10.1016\/j.ejps.2026.107602_bib0002","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3109\/03639045.2012.671831","article-title":"Vibrational spectroscopic investigation of polymorphs and cocrystals of indomethacin","volume":"39","author":"Ali","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"13","key":"10.1016\/j.ejps.2026.107602_bib0004","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.1021\/acs.cgd.5c00233","article-title":"Cocrystallization of caffeine with carboxylic acids and flavonoids: In vitro study to control the caffeine crash","volume":"25","author":"Baraldi","year":"2025","journal-title":"Cryst. Growth Des."},{"issue":"3","key":"10.1016\/j.ejps.2026.107602_bib0005","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s11095-007-9394-1","article-title":"Indomethacin\u2013saccharin cocrystal: Design, synthesis and preliminary pharmaceutical characterization","volume":"25","author":"Basavoju","year":"2008","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.ejps.2026.107602_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pcrysgrow.2016.07.001","article-title":"Spring and parachute: How cocrystals enhance solubility","volume":"62","author":"Bavishi","year":"2016","journal-title":"Prog. Cryst. Growth Charact. Mater."},{"issue":"13","key":"10.1016\/j.ejps.2026.107602_bib0007","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1021\/acs.cgd.5c00491","article-title":"Caffeine vs. theophylline cocrystals: Insights into structure\u2013mechanical behavior and piezoelectricity","volume":"25","author":"Bhowmik","year":"2025","journal-title":"Cryst. Growth Des."},{"issue":"8","key":"10.1016\/j.ejps.2026.107602_bib0008","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1002\/jps.21650","article-title":"Supersaturating drug delivery systems: The answer to solubility-limited oral bioavailability?","volume":"98","author":"Brouwers","year":"2009","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ejps.2026.107602_bib0010","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ejpb.2013.02.007","article-title":"Characteristics of indomethacin\u2013saccharin (IMC\u2013SAC) cocrystals prepared by an anti-solvent crystallization process","volume":"85","author":"Chun","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.ejps.2026.107602_bib0011","doi-asserted-by":"crossref","DOI":"10.15446\/rcciquifa.v48n3.84987","article-title":"An\u00e1lisis por FTIR y DSC de complejos polielectrolito entre Eudragit\u00ae E100 y \u00e1cido benzoico como evidencia de hidr\u00f3lisis de los grupos \u00e9ster del pol\u00edmero","volume":"48","author":"Dallos","year":"2019","journal-title":"Rev. Colomb. Cienc. Qu\u00edm. Farm."},{"issue":"1","key":"10.1016\/j.ejps.2026.107602_bib0012","article-title":"Preparation, characterization and evaluation of fenofibrate: Benzoic acid cocrystals with enhanced pharmaceutical properties","volume":"7","author":"Dutt","year":"2021","journal-title":"Future J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ejps.2026.107602_bib41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s13659-020-00256-y","article-title":"Crystal structures, stability, and solubility evaluation of a 2:1 diosgenin\u2013piperazine cocrystal","volume":"10","author":"Gong","year":"2020","journal-title":"Nat. Prod. Bioprospect."},{"key":"10.1016\/j.ejps.2026.107602_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.cep.2024.110108","article-title":"Intensified solid-state transformation during anti-solvent cocrystallization in flow","volume":"208","author":"Gupta","year":"2025","journal-title":"Chem. Eng. Process. Process Intensif."},{"issue":"10","key":"10.1016\/j.ejps.2026.107602_bib0016","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1021\/acs.cgd.8b00933","article-title":"Creating cocrystals: A review of pharmaceutical cocrystal preparation routes and applications","volume":"18","author":"Karimi-Jafari","year":"2018","journal-title":"Cryst. Growth Des."},{"issue":"1","key":"10.1016\/j.ejps.2026.107602_bib0017","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/15421406.2019.1577462","article-title":"Approaches to design of pharmaceutical cocrystals: A review","volume":"667","author":"Kumar","year":"2018","journal-title":"Mol. Cryst. Liq. Cryst."},{"issue":"7","key":"10.1016\/j.ejps.2026.107602_bib0018","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1080\/03639045.2018.1435687","article-title":"Development of paracetamol\u2013caffeine cocrystals to improve compressional, formulation and in vivo performance","volume":"44","author":"Latif","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"20","key":"10.1016\/j.ejps.2026.107602_bib40","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1039\/b926536h","article-title":"A study into the effect of subtle structural details and disorder on the terahertz spectrum of crystalline benzoic acid","volume":"12","author":"Li","year":"2010","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"11","key":"10.1016\/j.ejps.2026.107602_bib0019","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3390\/pharmaceutics17111399","article-title":"Cocrystallization of ezetimibe with organic acids: Stoichiometric optimization for improved solubility and bioavailability","volume":"17","author":"Maharjan","year":"2025","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.ejps.2026.107602_bib0020","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1021\/acs.oprd.8b00078","article-title":"Cooling crystallization of indomethacin: Effect of supersaturation, temperature, and seeding on polymorphism and crystal size distribution","volume":"22","author":"Malwade","year":"2018","journal-title":"Org. Process Res. Dev."},{"issue":"9","key":"10.1016\/j.ejps.2026.107602_bib0021","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.3390\/pharmaceutics14091881","article-title":"Formation thermodynamics of carbamazepine with benzamide, para-hydroxybenzamide and isonicotinamide cocrystals: Experimental and theoretical study","volume":"14","author":"Manin","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107602_bib0023","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.powtec.2012.02.020","article-title":"Improvement in physicochemical properties of ezetimibe using a crystal engineering technique","volume":"222","author":"Mulye","year":"2012","journal-title":"Powder Technol"},{"issue":"2","key":"10.1016\/j.ejps.2026.107602_bib0024","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1021\/cg0503346","article-title":"Phase solubility diagrams of cocrystals are explained by solubility product and solution complexation","volume":"6","author":"Nehm","year":"2006","journal-title":"Cryst. Growth Des."},{"issue":"11","key":"10.1016\/j.ejps.2026.107602_bib0025","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.3390\/molecules26113279","article-title":"Amino acids as the potential co-former for cocrystal development: a review","volume":"26","author":"Nugrahani","year":"2021","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.ejps.2026.107602_bib0027","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.3390\/ph18111610","article-title":"Enhancing the solubility of indomethacin: A breakthrough with cocrystal formation","volume":"18","author":"Pardo","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.ejps.2026.107602_bib0028","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3390\/cryst11030303","article-title":"Solution cocrystallization: A scalable approach for cocrystal production","volume":"11","author":"Pawar","year":"2021","journal-title":"Crystals"},{"issue":"27","key":"10.1016\/j.ejps.2026.107602_bib0029","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1039\/D4CE01170H","article-title":"The impact of crystal habit on the pharmaceutical properties of active pharmaceutical ingredients","volume":"27","author":"Ram","year":"2025","journal-title":"CrystEngComm"},{"issue":"3","key":"10.1016\/j.ejps.2026.107602_bib0031","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3390\/pharmaceutics10030108","article-title":"Engineering cocrystals of poorly water-soluble drugs to enhance dissolution in aqueous medium","volume":"10","author":"Sathisaran","year":"2018","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.ejps.2026.107602_bib0032","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1080\/10837450.2017.1334664","article-title":"Preparation and characterization of adefovir dipivoxil\u2013stearic acid cocrystal with enhanced physicochemical properties","volume":"23","author":"Seo","year":"2018","journal-title":"Pharm. Dev. Technol."},{"issue":"4","key":"10.1016\/j.ejps.2026.107602_bib0033","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1021\/je5011455","article-title":"Solid\u2013liquid phase equilibrium and ternary phase diagrams of ibuprofen\u2013nicotinamide cocrystals in ethanol and ethanol\/water mixtures at (298.15 and 313.15) K","volume":"60","author":"Sun","year":"2015","journal-title":"J. Chem. Eng. Data"},{"issue":"7","key":"10.1016\/j.ejps.2026.107602_bib0035","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1021\/cg900002q","article-title":"Thermodynamic and structural aspects of some fenamate molecular crystals","volume":"9","author":"Surov","year":"2009","journal-title":"Cryst. Growth Des."},{"issue":"1","key":"10.1016\/j.ejps.2026.107602_bib0036","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijpharm.2012.10.043","article-title":"Pharmaceutical cocrystals and poorly soluble drugs","volume":"453","author":"Thakuria","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2026.107602_bib0037","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijpharm.2013.04.012","article-title":"Anti-solvent cocrystallization of carbamazepine and saccharin","volume":"450","author":"Wang","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ejps.2026.107602_bib0039","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3390\/pharmaceutics18030333","article-title":"Preparation of crystalline cefquinome free acid via reverse anti-solvent crystallization: Physicochemical characterization and pharmacokinetics in chickens","volume":"18","author":"Xu","year":"2026","journal-title":"Pharmaceutics"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726001764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726001764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:39:26Z","timestamp":1787107166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726001764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":32,"alternative-id":["S0928098726001764"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107602","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antisolvent crystallization of indomethacin cocrystals: Influence of coformers and solvent systems","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107602","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107602"}}